Press Releases Latest Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV Press Releases Year None202120202019201820172016201520142013 Oct 15, 2020 Theratechnologies Announces Financial Results For The Third Quarter Of Fiscal 2020 Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH Oct 05, 2020 Theratechnologies To Announce Financial Results For Third Quarter 2020 Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5 Sep 21, 2020 Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population Sep 10, 2020 Theratechnologies Announces Launch Of Trogarzo® In Germany Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020 Jul 23, 2020 Theratechnologies Reports That Tesamorelin Improves Liver Health Jul 16, 2020 Announcements In Conjunction With Theratechnologies Annual Meeting First page « Previous page ‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page › Last page » Displaying 51 - 60 of 268
Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV
Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH
Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020
